| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Hemoglobin | 53 | 2024 | 345 | 8.650 |
Why?
|
| DNA-Binding Proteins | 191 | 2024 | 9606 | 6.440 |
Why?
|
| Transcription Factors | 213 | 2024 | 12128 | 6.010 |
Why?
|
| GATA1 Transcription Factor | 82 | 2022 | 296 | 5.370 |
Why?
|
| Erythroid Cells | 30 | 2024 | 238 | 4.990 |
Why?
|
| Hematopoiesis | 74 | 2022 | 2049 | 4.920 |
Why?
|
| Repressor Proteins | 66 | 2024 | 2986 | 4.840 |
Why?
|
| Hematopoietic Stem Cells | 93 | 2022 | 3396 | 4.760 |
Why?
|
| Globins | 94 | 2021 | 404 | 4.650 |
Why?
|
| Nuclear Proteins | 67 | 2024 | 5796 | 4.610 |
Why?
|
| Embryonic Stem Cells | 36 | 2021 | 1263 | 4.260 |
Why?
|
| Carrier Proteins | 53 | 2024 | 4936 | 4.030 |
Why?
|
| Erythropoiesis | 59 | 2022 | 683 | 3.950 |
Why?
|
| gamma-Globins | 16 | 2024 | 106 | 3.820 |
Why?
|
| Zinc Fingers | 45 | 2024 | 579 | 3.560 |
Why?
|
| Gene Expression Regulation, Developmental | 55 | 2021 | 3612 | 3.400 |
Why?
|
| Hemoglobinopathies | 11 | 2021 | 99 | 2.940 |
Why?
|
| Cell Differentiation | 135 | 2022 | 11528 | 2.920 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 87 | 2005 | 195 | 2.420 |
Why?
|
| Chromatin | 37 | 2024 | 2960 | 2.410 |
Why?
|
| Enhancer Elements, Genetic | 24 | 2024 | 1363 | 2.380 |
Why?
|
| Pluripotent Stem Cells | 13 | 2018 | 799 | 2.160 |
Why?
|
| Thalassemia | 55 | 2016 | 267 | 2.120 |
Why?
|
| Gene Expression Regulation | 100 | 2024 | 11903 | 2.050 |
Why?
|
| Mice | 329 | 2024 | 81525 | 2.050 |
Why?
|
| beta-Thalassemia | 12 | 2024 | 236 | 2.020 |
Why?
|
| Anemia, Sickle Cell | 26 | 2024 | 1063 | 1.940 |
Why?
|
| Cell Lineage | 52 | 2022 | 2555 | 1.930 |
Why?
|
| Proto-Oncogene Proteins | 46 | 2015 | 4511 | 1.760 |
Why?
|
| Megakaryocytes | 26 | 2017 | 566 | 1.760 |
Why?
|
| Promoter Regions, Genetic | 50 | 2024 | 5789 | 1.740 |
Why?
|
| Animals | 402 | 2024 | 168459 | 1.710 |
Why?
|
| Base Sequence | 153 | 2021 | 12441 | 1.700 |
Why?
|
| Nuclear Matrix-Associated Proteins | 2 | 2024 | 38 | 1.690 |
Why?
|
| beta-Globins | 14 | 2021 | 111 | 1.670 |
Why?
|
| Gene Silencing | 18 | 2024 | 1509 | 1.610 |
Why?
|
| Transcription, Genetic | 84 | 2018 | 7594 | 1.560 |
Why?
|
| Hemoglobins | 15 | 2021 | 1525 | 1.550 |
Why?
|
| Embryo, Mammalian | 33 | 2019 | 1675 | 1.530 |
Why?
|
| Genes | 65 | 1993 | 1823 | 1.490 |
Why?
|
| Erythroid Precursor Cells | 25 | 2014 | 211 | 1.450 |
Why?
|
| GATA2 Transcription Factor | 31 | 2023 | 158 | 1.400 |
Why?
|
| DNA | 100 | 2024 | 7212 | 1.360 |
Why?
|
| Leukemia | 14 | 2018 | 1522 | 1.350 |
Why?
|
| Stem Cells | 34 | 2023 | 3522 | 1.280 |
Why?
|
| RNA-Binding Proteins | 8 | 2024 | 1897 | 1.280 |
Why?
|
| Retinoblastoma Protein | 7 | 2017 | 672 | 1.240 |
Why?
|
| Erythrocytes | 32 | 2016 | 2413 | 1.230 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 18 | 2018 | 790 | 1.230 |
Why?
|
| Leukemia, Erythroblastic, Acute | 19 | 2021 | 176 | 1.210 |
Why?
|
| Granulomatous Disease, Chronic | 24 | 1995 | 173 | 1.210 |
Why?
|
| Histones | 24 | 2020 | 2580 | 1.200 |
Why?
|
| Kruppel-Like Transcription Factors | 15 | 2017 | 504 | 1.190 |
Why?
|
| Hemoglobin A | 3 | 2021 | 84 | 1.180 |
Why?
|
| Epigenesis, Genetic | 23 | 2023 | 3802 | 1.130 |
Why?
|
| Gene Regulatory Networks | 11 | 2022 | 1745 | 1.110 |
Why?
|
| Cell Line | 88 | 2020 | 15601 | 1.070 |
Why?
|
| Molecular Sequence Data | 103 | 2015 | 17635 | 1.060 |
Why?
|
| Homeodomain Proteins | 20 | 2021 | 2416 | 1.040 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2022 | 305 | 1.020 |
Why?
|
| Cloning, Molecular | 63 | 2004 | 4174 | 0.990 |
Why?
|
| Trans-Activators | 23 | 2013 | 2856 | 0.980 |
Why?
|
| Mice, Knockout | 73 | 2021 | 14414 | 0.960 |
Why?
|
| Mice, Transgenic | 53 | 2021 | 9539 | 0.940 |
Why?
|
| Gene Deletion | 19 | 2018 | 2665 | 0.930 |
Why?
|
| RNA Interference | 17 | 2020 | 2831 | 0.920 |
Why?
|
| Adenosine Deaminase | 15 | 2016 | 251 | 0.920 |
Why?
|
| Multiprotein Complexes | 8 | 2015 | 1118 | 0.890 |
Why?
|
| Cytochrome b Group | 20 | 1995 | 59 | 0.880 |
Why?
|
| Gene Targeting | 22 | 2013 | 838 | 0.870 |
Why?
|
| Neoplastic Stem Cells | 6 | 2018 | 1347 | 0.860 |
Why?
|
| X Chromosome | 29 | 2002 | 816 | 0.840 |
Why?
|
| Mesoderm | 12 | 2020 | 674 | 0.830 |
Why?
|
| Leukemia, Myeloid | 5 | 2023 | 694 | 0.830 |
Why?
|
| Down Syndrome | 9 | 2018 | 901 | 0.830 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 29 | 2015 | 1136 | 0.830 |
Why?
|
| Histone-Lysine N-Methyltransferase | 15 | 2018 | 682 | 0.820 |
Why?
|
| Erythroblasts | 14 | 2020 | 142 | 0.810 |
Why?
|
| Mutagenesis | 11 | 2019 | 1232 | 0.800 |
Why?
|
| Protein Binding | 35 | 2024 | 9351 | 0.770 |
Why?
|
| Adult Stem Cells | 3 | 2013 | 221 | 0.770 |
Why?
|
| Multipotent Stem Cells | 6 | 2022 | 200 | 0.750 |
Why?
|
| Single-Cell Analysis | 10 | 2018 | 2449 | 0.750 |
Why?
|
| CCAAT-Binding Factor | 1 | 2021 | 21 | 0.750 |
Why?
|
| Lymphopoiesis | 4 | 2022 | 133 | 0.750 |
Why?
|
| Histone Demethylases | 7 | 2016 | 320 | 0.750 |
Why?
|
| Integrases | 11 | 2017 | 516 | 0.740 |
Why?
|
| Transcriptional Activation | 16 | 2021 | 1756 | 0.720 |
Why?
|
| Osteosarcoma | 4 | 2017 | 897 | 0.720 |
Why?
|
| Hematology | 2 | 2017 | 243 | 0.720 |
Why?
|
| Gene Expression Profiling | 29 | 2018 | 9420 | 0.710 |
Why?
|
| Embryonic and Fetal Development | 14 | 2001 | 420 | 0.700 |
Why?
|
| Protein Multimerization | 2 | 2024 | 983 | 0.690 |
Why?
|
| Genetic Engineering | 8 | 2018 | 933 | 0.690 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2020 | 183 | 0.680 |
Why?
|
| DNA, Intergenic | 2 | 2017 | 105 | 0.680 |
Why?
|
| Endonucleases | 6 | 2019 | 371 | 0.670 |
Why?
|
| Binding Sites | 34 | 2024 | 6055 | 0.670 |
Why?
|
| Genome-Wide Association Study | 15 | 2024 | 12690 | 0.670 |
Why?
|
| Humans | 381 | 2024 | 761504 | 0.670 |
Why?
|
| Polymerase Chain Reaction | 29 | 2013 | 6075 | 0.670 |
Why?
|
| Cells, Cultured | 58 | 2020 | 18965 | 0.660 |
Why?
|
| Chromatin Assembly and Disassembly | 6 | 2016 | 633 | 0.660 |
Why?
|
| Octamer Transcription Factor-3 | 6 | 2020 | 223 | 0.660 |
Why?
|
| Amino Acid Sequence | 66 | 2010 | 13446 | 0.640 |
Why?
|
| Chromatin Immunoprecipitation | 15 | 2022 | 855 | 0.630 |
Why?
|
| DNA Methylation | 13 | 2019 | 4398 | 0.620 |
Why?
|
| Receptor, Endothelin B | 1 | 2018 | 46 | 0.610 |
Why?
|
| Nucleoside Deaminases | 12 | 1989 | 58 | 0.610 |
Why?
|
| Mast Cells | 11 | 2008 | 1392 | 0.600 |
Why?
|
| Thrombopoietin | 4 | 2015 | 226 | 0.590 |
Why?
|
| Bone Marrow | 15 | 2016 | 2911 | 0.590 |
Why?
|
| Chromosomal Proteins, Non-Histone | 8 | 2021 | 727 | 0.580 |
Why?
|
| Co-Repressor Proteins | 3 | 2014 | 190 | 0.580 |
Why?
|
| Methylation | 17 | 2018 | 1084 | 0.580 |
Why?
|
| Yolk Sac | 11 | 2012 | 79 | 0.580 |
Why?
|
| Genomic Imprinting | 3 | 2015 | 329 | 0.570 |
Why?
|
| Cell Division | 17 | 2011 | 4465 | 0.570 |
Why?
|
| Genes, Regulator | 4 | 2008 | 373 | 0.560 |
Why?
|
| Zebrafish Proteins | 7 | 2015 | 1014 | 0.550 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 3 | 2019 | 113 | 0.550 |
Why?
|
| Mutation | 72 | 2023 | 30052 | 0.550 |
Why?
|
| Mutagenesis, Site-Directed | 11 | 2010 | 1693 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 50 | 2021 | 22169 | 0.540 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2017 | 129 | 0.540 |
Why?
|
| Targeted Gene Repair | 1 | 2016 | 20 | 0.540 |
Why?
|
| RNA, Messenger | 70 | 2020 | 12795 | 0.530 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 5 | 2010 | 48 | 0.520 |
Why?
|
| Induced Pluripotent Stem Cells | 6 | 2019 | 1860 | 0.520 |
Why?
|
| Cell Cycle | 14 | 2019 | 2932 | 0.520 |
Why?
|
| Hematopoietic System | 7 | 2013 | 110 | 0.510 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2015 | 10 | 0.510 |
Why?
|
| Awards and Prizes | 2 | 2017 | 360 | 0.510 |
Why?
|
| Protein Isoforms | 5 | 2019 | 1699 | 0.510 |
Why?
|
| GATA Transcription Factors | 2 | 2015 | 29 | 0.500 |
Why?
|
| Translocation, Genetic | 3 | 2016 | 1393 | 0.500 |
Why?
|
| Alcohol Oxidoreductases | 4 | 2010 | 169 | 0.500 |
Why?
|
| Gene Expression | 35 | 2021 | 7581 | 0.500 |
Why?
|
| Protein Biosynthesis | 12 | 2020 | 2113 | 0.500 |
Why?
|
| Myelopoiesis | 6 | 2016 | 134 | 0.490 |
Why?
|
| Gene Expression Regulation, Leukemic | 10 | 2018 | 651 | 0.490 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2016 | 2825 | 0.490 |
Why?
|
| Oxidoreductases, N-Demethylating | 3 | 2015 | 110 | 0.480 |
Why?
|
| Apoptosis | 22 | 2018 | 9486 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2019 | 988 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2019 | 8547 | 0.460 |
Why?
|
| Viral Proteins | 7 | 2005 | 1804 | 0.460 |
Why?
|
| Transfection | 38 | 2015 | 5774 | 0.460 |
Why?
|
| Bone Neoplasms | 4 | 2017 | 2529 | 0.460 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2014 | 53 | 0.460 |
Why?
|
| Proteome | 3 | 2022 | 1862 | 0.460 |
Why?
|
| B-Lymphocytes | 12 | 2018 | 4758 | 0.460 |
Why?
|
| Biotinylation | 4 | 2020 | 184 | 0.460 |
Why?
|
| Lysine | 6 | 2018 | 993 | 0.460 |
Why?
|
| DNA Restriction Enzymes | 35 | 1988 | 550 | 0.450 |
Why?
|
| Sequence Deletion | 13 | 2016 | 1494 | 0.440 |
Why?
|
| Cell Proliferation | 26 | 2020 | 10445 | 0.430 |
Why?
|
| Erythropoietin | 11 | 2018 | 719 | 0.430 |
Why?
|
| DNA Footprinting | 3 | 2015 | 97 | 0.430 |
Why?
|
| Chromosome Deletion | 24 | 1994 | 1386 | 0.430 |
Why?
|
| Lymphocytes | 9 | 2018 | 2612 | 0.430 |
Why?
|
| Doxycycline | 1 | 2015 | 344 | 0.430 |
Why?
|
| Leukemia, Myeloid, Acute | 10 | 2022 | 3613 | 0.420 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2013 | 171 | 0.420 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2013 | 73 | 0.410 |
Why?
|
| Liver | 21 | 2018 | 7529 | 0.410 |
Why?
|
| Genetic Variation | 8 | 2018 | 6567 | 0.410 |
Why?
|
| Multigene Family | 11 | 2010 | 1076 | 0.410 |
Why?
|
| Medical Oncology | 2 | 2017 | 2321 | 0.400 |
Why?
|
| Mammary Glands, Animal | 2 | 2018 | 271 | 0.400 |
Why?
|
| Transgenes | 9 | 2012 | 1010 | 0.400 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2016 | 686 | 0.400 |
Why?
|
| Antigens, Surface | 6 | 2014 | 1606 | 0.400 |
Why?
|
| Chromosomes | 3 | 2024 | 577 | 0.400 |
Why?
|
| Fetal Heart | 3 | 2003 | 281 | 0.400 |
Why?
|
| Cell Line, Tumor | 26 | 2023 | 16981 | 0.400 |
Why?
|
| DNA, Recombinant | 16 | 1995 | 455 | 0.390 |
Why?
|
| DNA Primers | 20 | 2014 | 2819 | 0.390 |
Why?
|
| Heme | 5 | 2018 | 313 | 0.380 |
Why?
|
| K562 Cells | 11 | 2018 | 642 | 0.380 |
Why?
|
| Models, Genetic | 17 | 2018 | 3442 | 0.380 |
Why?
|
| MicroRNAs | 11 | 2022 | 3816 | 0.370 |
Why?
|
| Genetic Vectors | 22 | 2016 | 3395 | 0.360 |
Why?
|
| Signal Transduction | 30 | 2022 | 23445 | 0.360 |
Why?
|
| Phosphoglycerate Kinase | 8 | 1993 | 66 | 0.360 |
Why?
|
| Neutrophils | 14 | 2006 | 3767 | 0.360 |
Why?
|
| GATA4 Transcription Factor | 7 | 2012 | 124 | 0.360 |
Why?
|
| Genetic Loci | 8 | 2020 | 2632 | 0.360 |
Why?
|
| Genome | 10 | 2017 | 1740 | 0.350 |
Why?
|
| HEK293 Cells | 9 | 2021 | 4278 | 0.350 |
Why?
|
| SOXD Transcription Factors | 1 | 2010 | 44 | 0.350 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2010 | 68 | 0.350 |
Why?
|
| Genes, Reporter | 8 | 2020 | 1529 | 0.350 |
Why?
|
| 3T3 Cells | 14 | 2018 | 1085 | 0.340 |
Why?
|
| Bone Marrow Cells | 17 | 2018 | 2416 | 0.340 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 337 | 0.340 |
Why?
|
| Tumor Cells, Cultured | 21 | 2017 | 6132 | 0.340 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2015 | 1606 | 0.340 |
Why?
|
| Protein Precursors | 8 | 1992 | 1132 | 0.330 |
Why?
|
| Rhabdoid Tumor | 2 | 2002 | 210 | 0.330 |
Why?
|
| Genetic Linkage | 22 | 2011 | 2341 | 0.330 |
Why?
|
| Cell Nucleus | 11 | 2024 | 2909 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2017 | 2917 | 0.330 |
Why?
|
| Deoxyribonuclease I | 6 | 2014 | 224 | 0.330 |
Why?
|
| Plasmids | 15 | 2017 | 2269 | 0.330 |
Why?
|
| Zebrafish | 11 | 2017 | 3007 | 0.320 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 496 | 0.320 |
Why?
|
| Heart | 6 | 2017 | 4404 | 0.320 |
Why?
|
| Chromosome Mapping | 32 | 2018 | 4615 | 0.320 |
Why?
|
| DNA, Complementary | 9 | 2007 | 1991 | 0.320 |
Why?
|
| Genes, p53 | 3 | 2016 | 712 | 0.320 |
Why?
|
| von Willebrand Factor | 6 | 1988 | 673 | 0.310 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 2116 | 0.310 |
Why?
|
| Phenotype | 34 | 2019 | 16591 | 0.310 |
Why?
|
| Cell Cycle Proteins | 12 | 2021 | 3448 | 0.310 |
Why?
|
| Molecular Targeted Therapy | 5 | 2019 | 2811 | 0.310 |
Why?
|
| Academies and Institutes | 1 | 2010 | 318 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 4 | 2009 | 4414 | 0.300 |
Why?
|
| Hemoglobins, Abnormal | 8 | 1987 | 119 | 0.300 |
Why?
|
| Gene Transfer Techniques | 6 | 2010 | 1206 | 0.300 |
Why?
|
| Computational Biology | 9 | 2018 | 3518 | 0.300 |
Why?
|
| Genes, Switch | 4 | 2017 | 48 | 0.290 |
Why?
|
| Thymus Gland | 6 | 2021 | 1243 | 0.290 |
Why?
|
| Interferons | 3 | 2016 | 706 | 0.290 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 422 | 0.290 |
Why?
|
| Oncogenes | 7 | 2022 | 1222 | 0.290 |
Why?
|
| Mice, Mutant Strains | 10 | 2016 | 1749 | 0.290 |
Why?
|
| Helix-Loop-Helix Motifs | 8 | 2004 | 96 | 0.290 |
Why?
|
| Genomics | 7 | 2023 | 5821 | 0.280 |
Why?
|
| Phosphoproteins | 4 | 2018 | 2448 | 0.280 |
Why?
|
| Gene Dosage | 4 | 2017 | 1217 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 16 | 2015 | 4575 | 0.270 |
Why?
|
| Blood Platelets | 7 | 2014 | 2479 | 0.270 |
Why?
|
| Peptides | 4 | 2013 | 4358 | 0.270 |
Why?
|
| Receptor, TIE-2 | 2 | 2005 | 176 | 0.270 |
Why?
|
| Nucleic Acid Amplification Techniques | 4 | 1990 | 330 | 0.270 |
Why?
|
| Cell Survival | 14 | 2020 | 5791 | 0.270 |
Why?
|
| Eosinophils | 6 | 2004 | 950 | 0.270 |
Why?
|
| Metalloproteins | 5 | 2004 | 101 | 0.270 |
Why?
|
| Flow Cytometry | 18 | 2020 | 5869 | 0.270 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 321 | 0.260 |
Why?
|
| Anemia | 11 | 2022 | 1509 | 0.260 |
Why?
|
| Genome, Human | 11 | 2023 | 4425 | 0.260 |
Why?
|
| Proteomics | 5 | 2017 | 3849 | 0.260 |
Why?
|
| Embryo Research | 1 | 2006 | 38 | 0.260 |
Why?
|
| RNA Splicing | 13 | 2018 | 918 | 0.260 |
Why?
|
| GATA3 Transcription Factor | 11 | 2001 | 152 | 0.260 |
Why?
|
| Testis | 3 | 2003 | 794 | 0.250 |
Why?
|
| Epithelial Cells | 7 | 2023 | 3673 | 0.250 |
Why?
|
| Age Factors | 5 | 2020 | 18395 | 0.250 |
Why?
|
| Microarray Analysis | 4 | 2018 | 749 | 0.240 |
Why?
|
| Genetic Techniques | 1 | 2007 | 427 | 0.240 |
Why?
|
| Protein Processing, Post-Translational | 7 | 2018 | 1974 | 0.240 |
Why?
|
| NF-E2 Transcription Factor | 12 | 1999 | 38 | 0.240 |
Why?
|
| RNA, Small Interfering | 7 | 2020 | 3429 | 0.240 |
Why?
|
| Endothelium, Vascular | 7 | 2012 | 4431 | 0.240 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 12 | 1999 | 53 | 0.240 |
Why?
|
| Embryonic Development | 6 | 2018 | 721 | 0.240 |
Why?
|
| Intestines | 5 | 2023 | 1909 | 0.230 |
Why?
|
| Fetal Proteins | 2 | 2004 | 98 | 0.230 |
Why?
|
| Kinetics | 13 | 2024 | 6374 | 0.230 |
Why?
|
| Nucleic Acid Hybridization | 26 | 1990 | 1302 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2010 | 228 | 0.230 |
Why?
|
| Hemoglobin H | 4 | 1987 | 13 | 0.230 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 2 | 2008 | 51 | 0.230 |
Why?
|
| Prenatal Diagnosis | 13 | 1985 | 1265 | 0.230 |
Why?
|
| Proteins | 7 | 2008 | 6032 | 0.230 |
Why?
|
| Retroviridae | 12 | 2015 | 850 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2018 | 17904 | 0.220 |
Why?
|
| Conserved Sequence | 6 | 2014 | 1163 | 0.220 |
Why?
|
| Hybrid Cells | 13 | 1999 | 422 | 0.220 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 382 | 0.220 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 3847 | 0.220 |
Why?
|
| Myeloid Cells | 4 | 2014 | 823 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2015 | 698 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 9 | 2008 | 3792 | 0.220 |
Why?
|
| In Situ Hybridization | 10 | 2016 | 1900 | 0.220 |
Why?
|
| Cell Transdifferentiation | 2 | 2017 | 185 | 0.220 |
Why?
|
| Drosophila Proteins | 5 | 2015 | 1699 | 0.210 |
Why?
|
| Models, Molecular | 7 | 2024 | 5439 | 0.210 |
Why?
|
| Phagocytes | 10 | 1995 | 295 | 0.210 |
Why?
|
| Models, Biological | 14 | 2015 | 9469 | 0.210 |
Why?
|
| Histone Deacetylases | 3 | 2017 | 719 | 0.210 |
Why?
|
| Protein Stability | 1 | 2024 | 578 | 0.210 |
Why?
|
| Myeloproliferative Disorders | 3 | 2016 | 613 | 0.210 |
Why?
|
| Leucine Zippers | 5 | 1996 | 116 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 3 | 2002 | 1349 | 0.210 |
Why?
|
| Integrin alpha2 | 1 | 2022 | 39 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2017 | 15936 | 0.200 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 699 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-ets | 5 | 2007 | 314 | 0.200 |
Why?
|
| Sex Determination Processes | 1 | 2002 | 60 | 0.200 |
Why?
|
| Endothelin-1 | 5 | 2018 | 302 | 0.200 |
Why?
|
| Platelet-Derived Growth Factor | 6 | 1990 | 618 | 0.200 |
Why?
|
| Chromosome Inversion | 1 | 2002 | 120 | 0.200 |
Why?
|
| Janus Kinase 2 | 2 | 2016 | 560 | 0.200 |
Why?
|
| Down-Regulation | 7 | 2018 | 2919 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2013 | 3778 | 0.200 |
Why?
|
| zeta-Globins | 1 | 2021 | 2 | 0.200 |
Why?
|
| Chromosomes, Human, 6-12 and X | 7 | 1985 | 69 | 0.200 |
Why?
|
| Species Specificity | 10 | 2015 | 2414 | 0.200 |
Why?
|
| Societies, Scientific | 2 | 2015 | 222 | 0.200 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 1117 | 0.190 |
Why?
|
| Polymorphism, Genetic | 22 | 2010 | 4243 | 0.190 |
Why?
|
| Myocytes, Cardiac | 4 | 2017 | 1668 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 452 | 0.190 |
Why?
|
| Fibroblasts | 12 | 2019 | 4141 | 0.190 |
Why?
|
| Antithrombin III | 4 | 1985 | 128 | 0.190 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2020 | 20 | 0.190 |
Why?
|
| Placenta | 6 | 2015 | 1709 | 0.190 |
Why?
|
| Hospitals, Pediatric | 1 | 2010 | 1860 | 0.190 |
Why?
|
| Mitochondria | 6 | 2018 | 3624 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2017 | 3602 | 0.190 |
Why?
|
| Bone Marrow Transplantation | 10 | 2014 | 2693 | 0.180 |
Why?
|
| Organ Specificity | 12 | 2018 | 1967 | 0.180 |
Why?
|
| International Cooperation | 1 | 2007 | 1422 | 0.180 |
Why?
|
| Interferon Regulatory Factors | 3 | 2022 | 261 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 6 | 2016 | 5671 | 0.180 |
Why?
|
| Macromolecular Substances | 12 | 2004 | 1434 | 0.180 |
Why?
|
| Histone Deacetylase 2 | 1 | 2020 | 72 | 0.180 |
Why?
|
| Response Elements | 1 | 2002 | 309 | 0.180 |
Why?
|
| T-Lymphocytes | 11 | 2021 | 10194 | 0.180 |
Why?
|
| Protein Transport | 4 | 2018 | 1967 | 0.180 |
Why?
|
| Gastric Mucosa | 1 | 2023 | 604 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2022 | 1435 | 0.180 |
Why?
|
| Transcription Factors, TFII | 1 | 2000 | 62 | 0.180 |
Why?
|
| Genes, Lethal | 6 | 2004 | 223 | 0.180 |
Why?
|
| Restriction Mapping | 11 | 2014 | 851 | 0.180 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 5 | 2012 | 359 | 0.180 |
Why?
|
| Blood Cells | 3 | 2001 | 305 | 0.180 |
Why?
|
| HeLa Cells | 12 | 2015 | 3093 | 0.170 |
Why?
|
| Endothelium | 7 | 2003 | 765 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2016 | 3429 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2018 | 2898 | 0.170 |
Why?
|
| Histone Deacetylase 1 | 1 | 2020 | 133 | 0.170 |
Why?
|
| Quinazolines | 2 | 2018 | 1371 | 0.170 |
Why?
|
| Blotting, Western | 12 | 2015 | 5035 | 0.170 |
Why?
|
| Body Patterning | 2 | 2004 | 632 | 0.170 |
Why?
|
| Lymphoma, T-Cell | 1 | 2002 | 304 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 9 | 2016 | 1612 | 0.170 |
Why?
|
| Endoderm | 1 | 2020 | 160 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2002 | 2748 | 0.170 |
Why?
|
| Protein Footprinting | 1 | 2019 | 10 | 0.170 |
Why?
|
| NADH, NADPH Oxidoreductases | 7 | 1992 | 94 | 0.170 |
Why?
|
| Cell Movement | 4 | 2020 | 5203 | 0.170 |
Why?
|
| Genes, myb | 2 | 2010 | 18 | 0.170 |
Why?
|
| Forecasting | 3 | 2018 | 2928 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 5305 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2017 | 1567 | 0.170 |
Why?
|
| Blotting, Northern | 11 | 2011 | 1545 | 0.170 |
Why?
|
| Genes, Homeobox | 3 | 1996 | 285 | 0.170 |
Why?
|
| Neoplasms | 10 | 2023 | 22170 | 0.170 |
Why?
|
| Sp1 Transcription Factor | 2 | 2002 | 140 | 0.170 |
Why?
|
| Guanine | 2 | 1999 | 279 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 5 | 2019 | 4740 | 0.170 |
Why?
|
| Gene Knockout Techniques | 4 | 2018 | 802 | 0.170 |
Why?
|
| Embryo, Nonmammalian | 6 | 2015 | 906 | 0.170 |
Why?
|
| Binding, Competitive | 1 | 2021 | 1141 | 0.170 |
Why?
|
| Meiosis | 2 | 2015 | 328 | 0.170 |
Why?
|
| Female | 92 | 2021 | 392644 | 0.170 |
Why?
|
| Acetylation | 4 | 2021 | 1055 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 14 | 2001 | 3734 | 0.170 |
Why?
|
| Stomach | 1 | 2023 | 696 | 0.160 |
Why?
|
| Coronary Vessels | 2 | 2001 | 3096 | 0.160 |
Why?
|
| Facial Paralysis | 1 | 2023 | 346 | 0.160 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2003 | 1062 | 0.160 |
Why?
|
| Central Nervous System | 2 | 2004 | 1336 | 0.160 |
Why?
|
| Recombination, Genetic | 8 | 2007 | 1519 | 0.160 |
Why?
|
| Ferrochelatase | 1 | 2018 | 47 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 9 | 1999 | 1058 | 0.160 |
Why?
|
| Amino Acid Substitution | 6 | 2016 | 1738 | 0.160 |
Why?
|
| Estrogens | 2 | 1996 | 1522 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 412 | 0.160 |
Why?
|
| Animals, Newborn | 4 | 2016 | 2678 | 0.160 |
Why?
|
| Structure-Activity Relationship | 6 | 2013 | 3076 | 0.160 |
Why?
|
| Hemolysis | 2 | 2000 | 415 | 0.160 |
Why?
|
| Genes, ras | 2 | 2016 | 654 | 0.150 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2019 | 103 | 0.150 |
Why?
|
| Alleles | 18 | 2014 | 6863 | 0.150 |
Why?
|
| Hemangioblasts | 2 | 2015 | 28 | 0.150 |
Why?
|
| Interferon-gamma | 7 | 2011 | 3162 | 0.150 |
Why?
|
| Ovary | 2 | 2002 | 959 | 0.150 |
Why?
|
| TATA Box | 2 | 1995 | 127 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 2373 | 0.150 |
Why?
|
| Fetus | 6 | 2018 | 1863 | 0.150 |
Why?
|
| Lymphoma | 5 | 2016 | 1901 | 0.150 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2017 | 25 | 0.150 |
Why?
|
| History, 20th Century | 2 | 2017 | 2767 | 0.150 |
Why?
|
| Receptors, Estrogen | 3 | 2000 | 2208 | 0.150 |
Why?
|
| Oligodeoxyribonucleotides | 8 | 1997 | 779 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 837 | 0.150 |
Why?
|
| Thrombopoiesis | 2 | 2010 | 165 | 0.150 |
Why?
|
| Crosses, Genetic | 6 | 2004 | 749 | 0.150 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2001 | 307 | 0.150 |
Why?
|
| Neoplasm Proteins | 7 | 2018 | 3617 | 0.150 |
Why?
|
| Epigenomics | 3 | 2019 | 943 | 0.150 |
Why?
|
| Membrane Glycoproteins | 7 | 2015 | 3702 | 0.150 |
Why?
|
| Barrett Esophagus | 1 | 2021 | 492 | 0.150 |
Why?
|
| Dimerization | 2 | 2010 | 891 | 0.150 |
Why?
|
| Neuroblastoma | 2 | 2019 | 1250 | 0.150 |
Why?
|
| Trophoblasts | 2 | 2015 | 224 | 0.140 |
Why?
|
| Recombinant Proteins | 15 | 2011 | 6534 | 0.140 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2011 | 286 | 0.140 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2008 | 77 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2015 | 2057 | 0.140 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 4 | 1989 | 166 | 0.140 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2017 | 57 | 0.140 |
Why?
|
| Male | 67 | 2021 | 360804 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 3639 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myb | 3 | 2011 | 79 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7407 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 1551 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2017 | 484 | 0.130 |
Why?
|
| Receptors, Notch | 2 | 2015 | 743 | 0.130 |
Why?
|
| Morphogenesis | 4 | 2013 | 741 | 0.130 |
Why?
|
| Molecular Sequence Annotation | 2 | 2018 | 522 | 0.130 |
Why?
|
| Endoribonucleases | 1 | 2018 | 228 | 0.130 |
Why?
|
| Colony-Forming Units Assay | 4 | 2006 | 352 | 0.130 |
Why?
|
| Antigens | 4 | 2001 | 1443 | 0.130 |
Why?
|
| cdc25 Phosphatases | 1 | 2015 | 60 | 0.130 |
Why?
|
| Embryology | 1 | 1996 | 30 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 2017 | 286 | 0.130 |
Why?
|
| Cell Compartmentation | 1 | 2016 | 384 | 0.130 |
Why?
|
| Up-Regulation | 5 | 2018 | 4124 | 0.130 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2017 | 165 | 0.130 |
Why?
|
| Inosine | 1 | 2016 | 130 | 0.130 |
Why?
|
| Spinal Cord | 2 | 2005 | 1818 | 0.130 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 112 | 0.130 |
Why?
|
| Gaucher Disease | 1 | 2016 | 110 | 0.130 |
Why?
|
| Oncogene Proteins | 2 | 2017 | 718 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2014 | 727 | 0.130 |
Why?
|
| Karyotyping | 7 | 2012 | 1171 | 0.130 |
Why?
|
| Antineoplastic Agents | 4 | 2018 | 13639 | 0.130 |
Why?
|
| Chimerism | 1 | 2016 | 155 | 0.120 |
Why?
|
| Pediatrics | 1 | 2010 | 3589 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Myoblasts, Cardiac | 1 | 2015 | 21 | 0.120 |
Why?
|
| Adenine | 2 | 1999 | 987 | 0.120 |
Why?
|
| Neoplasms, Experimental | 3 | 2015 | 1229 | 0.120 |
Why?
|
| Acids | 1 | 2015 | 125 | 0.120 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 85 | 0.120 |
Why?
|
| Blood Vessels | 2 | 1999 | 1113 | 0.120 |
Why?
|
| Vertebrates | 3 | 2007 | 227 | 0.120 |
Why?
|
| RNA Editing | 1 | 2016 | 151 | 0.120 |
Why?
|
| Pregnancy | 24 | 2015 | 29874 | 0.120 |
Why?
|
| Endothelins | 2 | 1992 | 127 | 0.120 |
Why?
|
| Genotype | 11 | 2013 | 12990 | 0.120 |
Why?
|
| Superoxides | 8 | 1995 | 387 | 0.120 |
Why?
|
| Protein Interaction Mapping | 2 | 2009 | 616 | 0.120 |
Why?
|
| Angiopoietins | 1 | 2015 | 85 | 0.120 |
Why?
|
| Phosphorylation | 6 | 2016 | 8320 | 0.120 |
Why?
|
| Cell Culture Techniques | 3 | 2016 | 1667 | 0.120 |
Why?
|
| Serum | 1 | 2016 | 209 | 0.120 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2018 | 258 | 0.120 |
Why?
|
| Homozygote | 11 | 2004 | 1776 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 4 | 2016 | 2065 | 0.120 |
Why?
|
| Schwann Cells | 1 | 2015 | 197 | 0.120 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2016 | 431 | 0.120 |
Why?
|
| RNA | 10 | 2014 | 2726 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 2803 | 0.110 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 42 | 0.110 |
Why?
|
| Protein Subunits | 2 | 2015 | 943 | 0.110 |
Why?
|
| Megakaryocyte Progenitor Cells | 2 | 2010 | 28 | 0.110 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2013 | 75 | 0.110 |
Why?
|
| Software | 2 | 2019 | 4434 | 0.110 |
Why?
|
| Genetic Complementation Test | 3 | 2017 | 554 | 0.110 |
Why?
|
| Culture Media | 1 | 2016 | 897 | 0.110 |
Why?
|
| Evolution, Molecular | 2 | 2014 | 1886 | 0.110 |
Why?
|
| Penetrance | 2 | 2007 | 383 | 0.110 |
Why?
|
| Leucine | 1 | 2015 | 548 | 0.110 |
Why?
|
| Disease Progression | 4 | 2023 | 13506 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2021 | 774 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2016 | 350 | 0.110 |
Why?
|
| COS Cells | 2 | 2008 | 1130 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1994 | 783 | 0.110 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2015 | 612 | 0.110 |
Why?
|
| Natural Killer T-Cells | 1 | 2016 | 322 | 0.110 |
Why?
|
| Cadherins | 2 | 2015 | 903 | 0.110 |
Why?
|
| Mutation, Missense | 3 | 2016 | 2571 | 0.110 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2014 | 158 | 0.110 |
Why?
|
| Calpain | 1 | 2013 | 146 | 0.110 |
Why?
|
| Heterochromatin | 3 | 2018 | 293 | 0.110 |
Why?
|
| Sequence Alignment | 7 | 2019 | 2180 | 0.110 |
Why?
|
| Pain | 1 | 2008 | 5073 | 0.110 |
Why?
|
| Histone Code | 2 | 2018 | 158 | 0.110 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2012 | 22 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 476 | 0.110 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2013 | 99 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2020 | 815 | 0.110 |
Why?
|
| Cyclin D3 | 1 | 2012 | 54 | 0.100 |
Why?
|
| Hemophilia A | 1 | 2016 | 360 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 1745 | 0.100 |
Why?
|
| Blastocyst | 1 | 1996 | 433 | 0.100 |
Why?
|
| Spleen | 7 | 2016 | 2295 | 0.100 |
Why?
|
| Oocytes | 2 | 2015 | 1166 | 0.100 |
Why?
|
| Prostate | 2 | 2018 | 1770 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 976 | 0.100 |
Why?
|
| Transduction, Genetic | 3 | 2020 | 903 | 0.100 |
Why?
|
| MafK Transcription Factor | 4 | 1996 | 8 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2020 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 1600 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 502 | 0.100 |
Why?
|
| Streptavidin | 2 | 2009 | 82 | 0.100 |
Why?
|
| Membrane Proteins | 6 | 2018 | 7856 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 619 | 0.100 |
Why?
|
| Adult | 29 | 2022 | 221177 | 0.100 |
Why?
|
| Receptors, Erythropoietin | 5 | 2005 | 144 | 0.100 |
Why?
|
| Chimera | 7 | 2001 | 453 | 0.100 |
Why?
|
| Disease Models, Animal | 9 | 2017 | 18252 | 0.100 |
Why?
|
| Wnt Proteins | 1 | 2016 | 718 | 0.100 |
Why?
|
| Genetics, Medical | 1 | 2015 | 334 | 0.100 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1993 | 340 | 0.100 |
Why?
|
| Immunophenotyping | 3 | 2014 | 1870 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 2 | 1987 | 604 | 0.100 |
Why?
|
| Computer Simulation | 3 | 2017 | 6240 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2011 | 12 | 0.100 |
Why?
|
| Thrombocytopenia | 5 | 2002 | 1181 | 0.100 |
Why?
|
| Fetal Blood | 3 | 1996 | 1347 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 6 | 2015 | 416 | 0.100 |
Why?
|
| Monocytes | 3 | 1992 | 2570 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2016 | 921 | 0.100 |
Why?
|
| Iron | 3 | 2018 | 1793 | 0.100 |
Why?
|
| Cell Transplantation | 3 | 2016 | 472 | 0.100 |
Why?
|
| Carboxypeptidases | 1 | 1991 | 154 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 871 | 0.100 |
Why?
|
| Bacteriophage lambda | 3 | 1989 | 142 | 0.100 |
Why?
|
| Sciatic Nerve | 1 | 2015 | 617 | 0.100 |
Why?
|
| Macrophages | 8 | 2003 | 5769 | 0.100 |
Why?
|
| Mitochondrial Membranes | 3 | 2018 | 176 | 0.100 |
Why?
|
| Receptors, Cell Surface | 4 | 1999 | 2822 | 0.100 |
Why?
|
| Codon | 5 | 1989 | 601 | 0.100 |
Why?
|
| Adenosine | 1 | 2016 | 808 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 733 | 0.090 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2012 | 138 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2865 | 0.090 |
Why?
|
| Xenopus Proteins | 3 | 2001 | 434 | 0.090 |
Why?
|
| Myelin Sheath | 1 | 2015 | 653 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2015 | 842 | 0.090 |
Why?
|
| Chondrocytes | 1 | 2016 | 795 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 718 | 0.090 |
Why?
|
| Bromodeoxyuridine | 3 | 2004 | 311 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 736 | 0.090 |
Why?
|
| Hemoglobin, Sickle | 2 | 2010 | 113 | 0.090 |
Why?
|
| Moloney murine leukemia virus | 2 | 1987 | 109 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2018 | 901 | 0.090 |
Why?
|
| Fetal Death | 3 | 2000 | 435 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2016 | 2568 | 0.090 |
Why?
|
| Drosophila | 4 | 2015 | 1495 | 0.090 |
Why?
|
| Blood Group Antigens | 2 | 2012 | 184 | 0.090 |
Why?
|
| Physical Chromosome Mapping | 1 | 2010 | 183 | 0.090 |
Why?
|
| SUMO-1 Protein | 1 | 2010 | 35 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2011 | 192 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2023 | 1626 | 0.090 |
Why?
|
| Antigens, CD | 4 | 2015 | 4003 | 0.090 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2011 | 490 | 0.090 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 1990 | 14 | 0.090 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2015 | 600 | 0.090 |
Why?
|
| Wilms Tumor | 3 | 1994 | 379 | 0.090 |
Why?
|
| Eye Proteins | 1 | 1993 | 633 | 0.090 |
Why?
|
| Women's Health Services | 1 | 2010 | 88 | 0.090 |
Why?
|
| Intestinal Mucosa | 3 | 2016 | 3032 | 0.090 |
Why?
|
| Somatomedins | 1 | 2010 | 179 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 1961 | 0.090 |
Why?
|
| Cluster Analysis | 3 | 2016 | 2707 | 0.090 |
Why?
|
| Substrate Specificity | 2 | 2010 | 1791 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 7 | 2021 | 2547 | 0.080 |
Why?
|
| Amino Acid Motifs | 3 | 2014 | 931 | 0.080 |
Why?
|
| Cytosine | 1 | 2011 | 211 | 0.080 |
Why?
|
| Oligonucleotide Probes | 5 | 1995 | 416 | 0.080 |
Why?
|
| Cell Count | 6 | 2016 | 1835 | 0.080 |
Why?
|
| Trisomy | 1 | 2011 | 260 | 0.080 |
Why?
|
| Protein Conformation | 6 | 2001 | 3968 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 429 | 0.080 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 236 | 0.080 |
Why?
|
| DNA Modification Methylases | 1 | 2010 | 210 | 0.080 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 983 | 0.080 |
Why?
|
| DNA, Neoplasm | 10 | 2000 | 1745 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 878 | 0.080 |
Why?
|
| Inbreeding | 1 | 2008 | 48 | 0.080 |
Why?
|
| X Chromosome Inactivation | 1 | 2011 | 227 | 0.080 |
Why?
|
| Indicators and Reagents | 2 | 2001 | 462 | 0.080 |
Why?
|
| Eosinophilia | 1 | 2013 | 560 | 0.080 |
Why?
|
| GTP-Binding Proteins | 2 | 2010 | 951 | 0.080 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2009 | 103 | 0.080 |
Why?
|
| RNA, Untranslated | 3 | 2008 | 459 | 0.080 |
Why?
|
| Osteoclasts | 2 | 2005 | 711 | 0.080 |
Why?
|
| Mesonephros | 3 | 2015 | 42 | 0.080 |
Why?
|
| Interleukin-12 | 1 | 2011 | 584 | 0.080 |
Why?
|
| Chromatography, Affinity | 2 | 2009 | 532 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2001 | 1171 | 0.080 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 1987 | 69 | 0.080 |
Why?
|
| Cell Separation | 4 | 2010 | 1720 | 0.080 |
Why?
|
| Poly A | 3 | 1988 | 181 | 0.080 |
Why?
|
| Histone Acetyltransferases | 1 | 2010 | 336 | 0.080 |
Why?
|
| Neomycin | 2 | 1999 | 92 | 0.080 |
Why?
|
| Motor Neurons | 3 | 2023 | 870 | 0.080 |
Why?
|
| Exons | 10 | 1994 | 2391 | 0.080 |
Why?
|
| Antigens, Ly | 3 | 2014 | 295 | 0.080 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2008 | 11 | 0.080 |
Why?
|
| Killer Cells, Natural | 3 | 2015 | 2200 | 0.080 |
Why?
|
| Respiratory Burst | 2 | 2003 | 110 | 0.080 |
Why?
|
| Insulator Elements | 1 | 2008 | 27 | 0.080 |
Why?
|
| E2F Transcription Factors | 6 | 2010 | 269 | 0.080 |
Why?
|
| Kell Blood-Group System | 1 | 1988 | 21 | 0.080 |
Why?
|
| Science | 1 | 1990 | 239 | 0.070 |
Why?
|
| Heart Defects, Congenital | 2 | 2003 | 4671 | 0.070 |
Why?
|
| Gene Library | 6 | 2015 | 1059 | 0.070 |
Why?
|
| Transcription Factor TFIID | 2 | 2000 | 150 | 0.070 |
Why?
|
| Leukemia, T-Cell | 2 | 1999 | 101 | 0.070 |
Why?
|
| S Phase | 4 | 2001 | 421 | 0.070 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 1988 | 71 | 0.070 |
Why?
|
| Receptors, Cytokine | 2 | 1999 | 258 | 0.070 |
Why?
|
| Muscular Dystrophies | 2 | 1986 | 390 | 0.070 |
Why?
|
| Eye Neoplasms | 2 | 1986 | 307 | 0.070 |
Why?
|
| Tetracycline | 1 | 2007 | 216 | 0.070 |
Why?
|
| Immunohistochemistry | 8 | 2015 | 11076 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 624 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 4 | 1999 | 2688 | 0.070 |
Why?
|
| Microscopy, Confocal | 4 | 2015 | 1971 | 0.070 |
Why?
|
| Introns | 5 | 2015 | 981 | 0.070 |
Why?
|
| Blotting, Southern | 4 | 2010 | 777 | 0.070 |
Why?
|
| Molecular Weight | 8 | 1989 | 2186 | 0.070 |
Why?
|
| Bibliometrics | 1 | 2010 | 352 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 1285 | 0.070 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2007 | 124 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1188 | 0.070 |
Why?
|
| Gene Rearrangement | 3 | 2022 | 1125 | 0.070 |
Why?
|
| Retinoblastoma | 2 | 1986 | 317 | 0.070 |
Why?
|
| Gestational Age | 5 | 2005 | 3577 | 0.070 |
Why?
|
| Adipocytes | 2 | 2017 | 1194 | 0.070 |
Why?
|
| Lymphoid Tissue | 3 | 1998 | 445 | 0.070 |
Why?
|
| Antigens, CD34 | 4 | 2016 | 658 | 0.070 |
Why?
|
| Aging | 3 | 2003 | 8708 | 0.070 |
Why?
|
| Th1 Cells | 1 | 2011 | 1036 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 491 | 0.070 |
Why?
|
| Gonads | 2 | 2004 | 109 | 0.070 |
Why?
|
| Chickens | 5 | 2002 | 859 | 0.070 |
Why?
|
| DNA Probes | 4 | 1995 | 541 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2016 | 3065 | 0.070 |
Why?
|
| Cell Line, Transformed | 3 | 2009 | 867 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1989 | 489 | 0.060 |
Why?
|
| HMGB Proteins | 1 | 2005 | 45 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 6 | 1994 | 251 | 0.060 |
Why?
|
| Phagocytosis | 3 | 2003 | 1528 | 0.060 |
Why?
|
| Research Personnel | 1 | 2010 | 588 | 0.060 |
Why?
|
| Sex Chromosomes | 2 | 1983 | 101 | 0.060 |
Why?
|
| Granulocytes | 5 | 2016 | 551 | 0.060 |
Why?
|
| Autophagy | 1 | 2013 | 1326 | 0.060 |
Why?
|
| Androgens | 1 | 2013 | 1286 | 0.060 |
Why?
|
| Time Factors | 10 | 2010 | 39967 | 0.060 |
Why?
|
| Scientific Misconduct | 1 | 2006 | 74 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 151 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2015 | 1646 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2006 | 188 | 0.060 |
Why?
|
| Pedigree | 8 | 2011 | 4542 | 0.060 |
Why?
|
| Cleft Palate | 1 | 2010 | 589 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2007 | 852 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6484 | 0.060 |
Why?
|
| Methyltransferases | 1 | 2008 | 377 | 0.060 |
Why?
|
| Retinitis Pigmentosa | 1 | 1988 | 397 | 0.060 |
Why?
|
| Mice, Inbred Strains | 3 | 2013 | 1762 | 0.060 |
Why?
|
| Xenopus laevis | 3 | 2001 | 963 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 20098 | 0.060 |
Why?
|
| RNA, Helminth | 1 | 2004 | 60 | 0.060 |
Why?
|
| RNA Polymerase II | 3 | 2017 | 539 | 0.060 |
Why?
|
| Phylogeny | 2 | 2004 | 2811 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 460 | 0.060 |
Why?
|
| Parity | 1 | 2007 | 927 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1896 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2007 | 597 | 0.060 |
Why?
|
| Operon | 2 | 1984 | 372 | 0.060 |
Why?
|
| Drosophila melanogaster | 3 | 2001 | 1712 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2538 | 0.060 |
Why?
|
| Heterozygote | 7 | 2005 | 2787 | 0.060 |
Why?
|
| Australia | 1 | 2007 | 1250 | 0.060 |
Why?
|
| Gene Conversion | 1 | 1983 | 67 | 0.060 |
Why?
|
| Pyloric Antrum | 1 | 2023 | 66 | 0.060 |
Why?
|
| E2F1 Transcription Factor | 5 | 2001 | 178 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2005 | 546 | 0.060 |
Why?
|
| Cranial Nerves | 1 | 2004 | 98 | 0.060 |
Why?
|
| Guanosine | 1 | 2003 | 48 | 0.060 |
Why?
|
| Antithrombin III Deficiency | 1 | 1983 | 28 | 0.060 |
Why?
|
| Microscopy, Electron | 4 | 2015 | 2561 | 0.050 |
Why?
|
| Muramidase | 1 | 2003 | 169 | 0.050 |
Why?
|
| Interleukin-5 | 2 | 2002 | 269 | 0.050 |
Why?
|
| Base Composition | 4 | 1984 | 290 | 0.050 |
Why?
|
| Peroxidases | 1 | 2003 | 134 | 0.050 |
Why?
|
| Connective Tissue Cells | 1 | 2003 | 49 | 0.050 |
Why?
|
| Biological Evolution | 3 | 1988 | 1071 | 0.050 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2002 | 15 | 0.050 |
Why?
|
| Neurons, Efferent | 1 | 2023 | 81 | 0.050 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1982 | 64 | 0.050 |
Why?
|
| Progesterone Reductase | 1 | 2002 | 14 | 0.050 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 2002 | 24 | 0.050 |
Why?
|
| Steroid Isomerases | 1 | 2002 | 19 | 0.050 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2002 | 28 | 0.050 |
Why?
|
| Kidney | 5 | 2012 | 7048 | 0.050 |
Why?
|
| Nucleotides | 1 | 1985 | 454 | 0.050 |
Why?
|
| Sphenoid Bone | 1 | 2004 | 177 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 1985 | 365 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2016 | 3242 | 0.050 |
Why?
|
| Sertoli Cells | 1 | 2002 | 50 | 0.050 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2002 | 45 | 0.050 |
Why?
|
| Receptors, Growth Factor | 2 | 2000 | 326 | 0.050 |
Why?
|
| Adipogenesis | 1 | 2005 | 368 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2004 | 664 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10766 | 0.050 |
Why?
|
| Ascitic Fluid | 1 | 2003 | 189 | 0.050 |
Why?
|
| Algorithms | 4 | 2016 | 14031 | 0.050 |
Why?
|
| Phenylhydrazines | 1 | 2002 | 28 | 0.050 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2002 | 42 | 0.050 |
Why?
|
| Animals, Genetically Modified | 3 | 2015 | 1561 | 0.050 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2002 | 99 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2002 | 54 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1997 | 343 | 0.050 |
Why?
|
| Point Mutation | 5 | 2000 | 1595 | 0.050 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1982 | 175 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 1985 | 547 | 0.050 |
Why?
|
| Rats | 6 | 2015 | 23742 | 0.050 |
Why?
|
| Cardiovascular System | 2 | 2003 | 834 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2008 | 1651 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2008 | 1893 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2008 | 1206 | 0.050 |
Why?
|
| Gene Frequency | 5 | 2008 | 3606 | 0.050 |
Why?
|
| Peptide Mapping | 2 | 1994 | 262 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2010 | 1203 | 0.050 |
Why?
|
| High Mobility Group Proteins | 1 | 2002 | 177 | 0.050 |
Why?
|
| Simian virus 40 | 3 | 1991 | 291 | 0.050 |
Why?
|
| Serine | 1 | 2006 | 830 | 0.050 |
Why?
|
| Homeostasis | 3 | 2009 | 3323 | 0.050 |
Why?
|
| Heart Valves | 1 | 2003 | 284 | 0.050 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 2015 | 89 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 1827 | 0.050 |
Why?
|
| SOX9 Transcription Factor | 1 | 2002 | 145 | 0.050 |
Why?
|
| WT1 Proteins | 1 | 2002 | 184 | 0.050 |
Why?
|
| alpha-Globins | 1 | 2021 | 19 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 1985 | 754 | 0.050 |
Why?
|
| Genes, myc | 2 | 2010 | 390 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2001 | 90 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1991 | 1405 | 0.050 |
Why?
|
| Hemocytes | 1 | 2001 | 44 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 814 | 0.050 |
Why?
|
| Neural Crest | 1 | 2003 | 279 | 0.050 |
Why?
|
| Haplorhini | 2 | 1995 | 525 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2004 | 815 | 0.050 |
Why?
|
| Organoids | 2 | 2018 | 740 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2014 | 732 | 0.050 |
Why?
|
| Self Tolerance | 1 | 2001 | 123 | 0.050 |
Why?
|
| Hair Cells, Auditory, Inner | 1 | 2003 | 199 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2001 | 145 | 0.050 |
Why?
|
| Azacitidine | 1 | 1983 | 336 | 0.050 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 1998 | 113 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1578 | 0.050 |
Why?
|
| Lac Operon | 2 | 1998 | 237 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1994 | 410 | 0.050 |
Why?
|
| Metaplasia | 1 | 2021 | 322 | 0.050 |
Why?
|
| Biological Factors | 1 | 2002 | 157 | 0.050 |
Why?
|
| DNA, Single-Stranded | 1 | 2022 | 355 | 0.050 |
Why?
|
| Hematocrit | 1 | 2002 | 623 | 0.050 |
Why?
|
| Escherichia coli | 3 | 1989 | 4217 | 0.040 |
Why?
|
| Locus Control Region | 1 | 2020 | 21 | 0.040 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 2000 | 15 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2000 | 102 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 21012 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1493 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2004 | 487 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2000 | 124 | 0.040 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2020 | 57 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5671 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1993 | 310 | 0.040 |
Why?
|
| Consensus Sequence | 3 | 2000 | 365 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2000 | 186 | 0.040 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1999 | 23 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 1990 | 0.040 |
Why?
|
| HLA Antigens | 1 | 1985 | 1328 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2008 | 2469 | 0.040 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2000 | 187 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 1999 | 56 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2005 | 764 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 2013 | 11118 | 0.040 |
Why?
|
| Valine | 1 | 2001 | 408 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2005 | 1330 | 0.040 |
Why?
|
| Interneurons | 2 | 2005 | 593 | 0.040 |
Why?
|
| Cryptorchidism | 1 | 2000 | 151 | 0.040 |
Why?
|
| Protoporphyrins | 2 | 2014 | 168 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 666 | 0.040 |
Why?
|
| Electroporation | 2 | 2015 | 255 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 709 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 216 | 0.040 |
Why?
|
| Hepatocytes | 2 | 2009 | 1233 | 0.040 |
Why?
|
| TCF Transcription Factors | 1 | 1999 | 138 | 0.040 |
Why?
|
| Infant, Newborn | 6 | 2022 | 26198 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2003 | 1341 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4369 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 1076 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 2 | 2011 | 421 | 0.040 |
Why?
|
| Urogenital System | 1 | 1998 | 88 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2002 | 774 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 1999 | 397 | 0.040 |
Why?
|
| Vitelline Membrane | 1 | 1998 | 3 | 0.040 |
Why?
|
| Chromosome Banding | 3 | 1988 | 260 | 0.040 |
Why?
|
| Cattle | 3 | 2000 | 3849 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2005 | 2257 | 0.040 |
Why?
|
| Brain | 3 | 2016 | 27112 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 1998 | 184 | 0.040 |
Why?
|
| Bacteria | 1 | 1989 | 2199 | 0.040 |
Why?
|
| Proto-Oncogenes | 2 | 2002 | 321 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 1995 | 91 | 0.040 |
Why?
|
| Thromboxane-A Synthase | 1 | 1997 | 34 | 0.040 |
Why?
|
| Leukemia, Experimental | 2 | 2016 | 225 | 0.040 |
Why?
|
| E2F2 Transcription Factor | 3 | 2001 | 35 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 574 | 0.040 |
Why?
|
| Clone Cells | 4 | 1992 | 1659 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 1976 | 133 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 857 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 592 | 0.040 |
Why?
|
| Glycolysis | 1 | 2022 | 835 | 0.040 |
Why?
|
| Growth Substances | 1 | 2000 | 768 | 0.040 |
Why?
|
| CREB-Binding Protein | 1 | 1998 | 148 | 0.040 |
Why?
|
| Lentivirus | 2 | 2010 | 508 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2003 | 655 | 0.040 |
Why?
|
| Cytokines | 3 | 2014 | 7396 | 0.040 |
Why?
|
| Astrocytes | 1 | 2005 | 1346 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 1998 | 310 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2000 | 910 | 0.040 |
Why?
|
| Boston | 1 | 2010 | 9326 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 1989 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2018 | 287 | 0.040 |
Why?
|
| CpG Islands | 2 | 2014 | 1230 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4915 | 0.040 |
Why?
|
| Placental Lactogen | 1 | 1997 | 17 | 0.040 |
Why?
|
| Neurons | 4 | 2016 | 9463 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5315 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2018 | 469 | 0.040 |
Why?
|
| RNA, Neoplasm | 3 | 2000 | 750 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2004 | 6216 | 0.040 |
Why?
|
| Glycoproteins | 3 | 2016 | 2203 | 0.030 |
Why?
|
| Lung | 2 | 2006 | 10000 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2000 | 563 | 0.030 |
Why?
|
| Genes, bcl-2 | 1 | 1997 | 119 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2023 | 863 | 0.030 |
Why?
|
| Antimetabolites | 1 | 2017 | 128 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2018 | 212 | 0.030 |
Why?
|
| Mucin-2 | 1 | 2016 | 50 | 0.030 |
Why?
|
| Genes, Recessive | 2 | 1990 | 623 | 0.030 |
Why?
|
| Saudi Arabia | 5 | 1989 | 210 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1997 | 361 | 0.030 |
Why?
|
| Ribonucleases | 2 | 2001 | 277 | 0.030 |
Why?
|
| Infant | 7 | 2015 | 36192 | 0.030 |
Why?
|
| Ribosomes | 1 | 2020 | 501 | 0.030 |
Why?
|
| Cytoskeleton | 3 | 2013 | 1170 | 0.030 |
Why?
|
| Kidney Neoplasms | 3 | 1994 | 4249 | 0.030 |
Why?
|
| Apolipoproteins A | 1 | 2016 | 95 | 0.030 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 1996 | 150 | 0.030 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2016 | 19 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2020 | 495 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2020 | 581 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 1999 | 340 | 0.030 |
Why?
|
| PPAR delta | 1 | 2016 | 40 | 0.030 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2015 | 25 | 0.030 |
Why?
|
| Receptors, Interferon | 1 | 2016 | 116 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2017 | 195 | 0.030 |
Why?
|
| Dimethylformamide | 2 | 1993 | 20 | 0.030 |
Why?
|
| Cell Transformation, Viral | 2 | 1987 | 526 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2018 | 469 | 0.030 |
Why?
|
| Janus Kinase 1 | 1 | 2016 | 107 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 364 | 0.030 |
Why?
|
| Pericardium | 1 | 2000 | 675 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 95 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1999 | 793 | 0.030 |
Why?
|
| Caspases | 1 | 2018 | 879 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2016 | 144 | 0.030 |
Why?
|
| Egg Yolk | 1 | 1995 | 24 | 0.030 |
Why?
|
| Myelin P0 Protein | 1 | 2015 | 15 | 0.030 |
Why?
|
| Genes, APC | 1 | 2016 | 145 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 4111 | 0.030 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2015 | 33 | 0.030 |
Why?
|
| Inflammation | 4 | 2022 | 10773 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1616 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2006 | 1642 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 6346 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1997 | 457 | 0.030 |
Why?
|
| Transcription Factor DP1 | 2 | 2010 | 136 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2015 | 68 | 0.030 |
Why?
|
| Antioxidants | 1 | 2003 | 1668 | 0.030 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2014 | 5 | 0.030 |
Why?
|
| Skull | 1 | 2020 | 818 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 129 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 1456 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 169 | 0.030 |
Why?
|
| Retroelements | 1 | 2016 | 163 | 0.030 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 2 | 1984 | 31 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2001 | 1741 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 1996 | 439 | 0.030 |
Why?
|
| Actins | 2 | 2000 | 2050 | 0.030 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
| Autoradiography | 2 | 1994 | 728 | 0.030 |
Why?
|
| Dopamine | 1 | 2002 | 1607 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2015 | 213 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 341 | 0.030 |
Why?
|
| Fetal Diseases | 2 | 1996 | 913 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1994 | 100 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2003 | 1390 | 0.030 |
Why?
|
| Receptors, Interleukin-3 | 1 | 2014 | 29 | 0.030 |
Why?
|
| Estradiol | 2 | 2000 | 1937 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2016 | 226 | 0.030 |
Why?
|
| Serine Endopeptidases | 2 | 2013 | 1022 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
| Tretinoin | 3 | 1993 | 519 | 0.030 |
Why?
|
| Oncogene Protein v-maf | 1 | 1993 | 5 | 0.030 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2014 | 22 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 226 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 464 | 0.030 |
Why?
|
| Models, Animal | 2 | 2011 | 2112 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2015 | 194 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 12148 | 0.030 |
Why?
|
| Genes, Wilms Tumor | 1 | 1994 | 92 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 774 | 0.030 |
Why?
|
| Kyphosis | 1 | 2016 | 237 | 0.030 |
Why?
|
| Hydroxyurea | 3 | 1984 | 284 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 1984 | 1768 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2022 | 4806 | 0.030 |
Why?
|
| Myocardium | 1 | 2006 | 4726 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2002 | 1600 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2022 | 2490 | 0.030 |
Why?
|
| DNA Transposable Elements | 2 | 2010 | 755 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2001 | 1356 | 0.030 |
Why?
|
| Immunoglobulin Fragments | 1 | 1973 | 84 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 789 | 0.030 |
Why?
|
| Cell Death | 2 | 2000 | 1678 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1998 | 851 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 1993 | 150 | 0.030 |
Why?
|
| Mammals | 1 | 1999 | 1132 | 0.030 |
Why?
|
| Syndrome | 3 | 2002 | 3267 | 0.030 |
Why?
|
| Hemoglobinuria, Paroxysmal | 2 | 2001 | 94 | 0.030 |
Why?
|
| Mice, Inbred C3H | 3 | 1993 | 915 | 0.030 |
Why?
|
| Granulocyte-Macrophage Progenitor Cells | 1 | 2012 | 21 | 0.030 |
Why?
|
| Phosphopeptides | 1 | 1994 | 240 | 0.030 |
Why?
|
| Italy | 2 | 2008 | 842 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 656 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3712 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2016 | 3548 | 0.030 |
Why?
|
| Actinin | 1 | 2013 | 163 | 0.030 |
Why?
|
| Reticulocytes | 3 | 2001 | 289 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 1405 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 345 | 0.030 |
Why?
|
| Sulfuric Acid Esters | 1 | 1992 | 32 | 0.030 |
Why?
|
| Disease | 1 | 2018 | 672 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 1998 | 981 | 0.030 |
Why?
|
| Porphyrins | 1 | 2014 | 352 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 1995 | 372 | 0.030 |
Why?
|
| Carboxypeptidases A | 1 | 1991 | 37 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2016 | 0.030 |
Why?
|
| Aminopterin | 1 | 1971 | 15 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 1668 | 0.020 |
Why?
|
| DNA Replication | 3 | 2014 | 1418 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 114 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2017 | 1641 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1993 | 430 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1994 | 569 | 0.020 |
Why?
|
| E2F3 Transcription Factor | 2 | 2001 | 36 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1995 | 545 | 0.020 |
Why?
|
| Sea Urchins | 1 | 1991 | 45 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 594 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 1903 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 902 | 0.020 |
Why?
|
| Free Radicals | 1 | 1992 | 238 | 0.020 |
Why?
|
| Child | 9 | 2022 | 80153 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 2 | 1988 | 116 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2012 | 200 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2012 | 123 | 0.020 |
Why?
|
| Chick Embryo | 2 | 2005 | 982 | 0.020 |
Why?
|
| Molecular Biology | 2 | 1990 | 576 | 0.020 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 2141 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2626 | 0.020 |
Why?
|
| Axons | 1 | 1999 | 1674 | 0.020 |
Why?
|
| Immune System | 1 | 2016 | 796 | 0.020 |
Why?
|
| Neuroglia | 1 | 2017 | 956 | 0.020 |
Why?
|
| Basophils | 1 | 1993 | 407 | 0.020 |
Why?
|
| beta Catenin | 1 | 2016 | 1040 | 0.020 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 1991 | 92 | 0.020 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2010 | 61 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2011 | 188 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 624 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2015 | 768 | 0.020 |
Why?
|
| Umbilical Veins | 2 | 1989 | 426 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2011 | 148 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 368 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 8599 | 0.020 |
Why?
|
| Asthma | 2 | 2011 | 6234 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 140 | 0.020 |
Why?
|
| RNA Probes | 1 | 1990 | 111 | 0.020 |
Why?
|
| Nucleoproteins | 1 | 2010 | 113 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1991 | 286 | 0.020 |
Why?
|
| Pyridones | 1 | 2015 | 809 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 370 | 0.020 |
Why?
|
| DNA Damage | 2 | 2014 | 2446 | 0.020 |
Why?
|
| DNA Repair | 2 | 2015 | 2045 | 0.020 |
Why?
|
| Anemia, Macrocytic | 1 | 2010 | 53 | 0.020 |
Why?
|
| Developmental Biology | 1 | 2010 | 79 | 0.020 |
Why?
|
| Recurrence | 1 | 2022 | 8465 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2016 | 803 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2010 | 436 | 0.020 |
Why?
|
| Regeneration | 1 | 2018 | 1511 | 0.020 |
Why?
|
| Core Binding Factors | 1 | 2009 | 29 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1638 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1990 | 153 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1989 | 19 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1376 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1989 | 76 | 0.020 |
Why?
|
| Genes, araC | 1 | 1989 | 2 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 2244 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 64680 | 0.020 |
Why?
|
| Salivary alpha-Amylases | 1 | 2009 | 15 | 0.020 |
Why?
|
| Oncogene Fusion | 1 | 2009 | 81 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2011 | 291 | 0.020 |
Why?
|
| Thrombosis | 1 | 1983 | 2942 | 0.020 |
Why?
|
| Stress, Physiological | 2 | 2010 | 1403 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3615 | 0.020 |
Why?
|
| Ligands | 1 | 1996 | 3272 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2009 | 130 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2012 | 1262 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 5777 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 1991 | 568 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2009 | 143 | 0.020 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 26 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 1250 | 0.020 |
Why?
|
| Biotin | 1 | 2009 | 254 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2008 | 1897 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 1410 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1999 | 2645 | 0.020 |
Why?
|
| Mitosis | 2 | 1999 | 1187 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2008 | 41487 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2011 | 345 | 0.020 |
Why?
|
| Blastomeres | 1 | 2008 | 29 | 0.020 |
Why?
|
| Insect Viruses | 1 | 1987 | 15 | 0.020 |
Why?
|
| Acridines | 1 | 1967 | 19 | 0.020 |
Why?
|
| Oxygen | 1 | 2020 | 4227 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2002 | 2877 | 0.020 |
Why?
|
| Amino Acids | 1 | 1994 | 1718 | 0.020 |
Why?
|
| Photosystem II Protein Complex | 1 | 1987 | 18 | 0.020 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2008 | 53 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2010 | 279 | 0.020 |
Why?
|
| Adolescent | 7 | 2008 | 88319 | 0.020 |
Why?
|
| Teratoma | 1 | 2011 | 404 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 209 | 0.020 |
Why?
|
| Th2 Cells | 2 | 2004 | 1060 | 0.020 |
Why?
|
| Cricetinae | 5 | 1985 | 2423 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 2 | 1984 | 310 | 0.020 |
Why?
|
| Research | 2 | 1999 | 1982 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4580 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1967 | 235 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1833 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1990 | 687 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 282 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2008 | 400 | 0.020 |
Why?
|
| Enterocytes | 1 | 2008 | 220 | 0.020 |
Why?
|
| Receptors, Thrombopoietin | 2 | 1999 | 160 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2010 | 384 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 1967 | 321 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2000 | 664 | 0.020 |
Why?
|
| Amniotic Fluid | 2 | 1979 | 378 | 0.020 |
Why?
|
| GATA6 Transcription Factor | 1 | 2006 | 50 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2645 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1987 | 767 | 0.020 |
Why?
|
| Amniocentesis | 2 | 1984 | 115 | 0.020 |
Why?
|
| Aotus trivirgatus | 1 | 1986 | 36 | 0.020 |
Why?
|
| Cebidae | 1 | 1986 | 21 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1858 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2012 | 1111 | 0.020 |
Why?
|
| Hungary | 1 | 1986 | 82 | 0.020 |
Why?
|
| Uterus | 1 | 1990 | 649 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 1541 | 0.020 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1985 | 30 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2016 | 3208 | 0.020 |
Why?
|
| Disulfides | 1 | 1988 | 465 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2006 | 104 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 290 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1987 | 406 | 0.020 |
Why?
|
| Symporters | 1 | 2008 | 363 | 0.020 |
Why?
|
| Catalase | 1 | 1986 | 218 | 0.020 |
Why?
|
| Piperazines | 1 | 2016 | 2523 | 0.020 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1985 | 32 | 0.020 |
Why?
|
| Graft vs Host Disease | 2 | 2016 | 3029 | 0.020 |
Why?
|
| Commerce | 1 | 1990 | 606 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2005 | 203 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2872 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2012 | 980 | 0.020 |
Why?
|
| Cesium Radioisotopes | 1 | 2004 | 38 | 0.020 |
Why?
|
| Angiotensinogen | 1 | 1985 | 161 | 0.020 |
Why?
|
| Child, Preschool | 5 | 2015 | 42230 | 0.020 |
Why?
|
| RNA, Ribosomal | 2 | 1976 | 227 | 0.020 |
Why?
|
| Horses | 1 | 1985 | 300 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1985 | 167 | 0.010 |
Why?
|
| Fibrosis | 1 | 2012 | 2049 | 0.010 |
Why?
|
| Interferon Type I | 1 | 1988 | 562 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 84 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3575 | 0.010 |
Why?
|
| Rabbits | 1 | 1990 | 4772 | 0.010 |
Why?
|
| Haplotypes | 2 | 1989 | 2713 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 2004 | 124 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1984 | 103 | 0.010 |
Why?
|
| Chorionic Villi | 1 | 1984 | 53 | 0.010 |
Why?
|
| Peptide Fragments | 3 | 1986 | 5112 | 0.010 |
Why?
|
| Virion | 1 | 1986 | 422 | 0.010 |
Why?
|
| Folic Acid Antagonists | 2 | 1976 | 75 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3092 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 714 | 0.010 |
Why?
|
| Leukocyte Count | 2 | 2004 | 1596 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 1986 | 256 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1985 | 677 | 0.010 |
Why?
|
| Cyprus | 1 | 1983 | 96 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2003 | 51 | 0.010 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 1983 | 49 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 2000 | 3597 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2223 | 0.010 |
Why?
|
| Phenylalanine | 1 | 2004 | 366 | 0.010 |
Why?
|
| Beta-Globulins | 1 | 1982 | 27 | 0.010 |
Why?
|
| Organ of Corti | 1 | 2003 | 85 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 273 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2735 | 0.010 |
Why?
|
| Ependyma | 1 | 2002 | 56 | 0.010 |
Why?
|
| Mucus | 1 | 2004 | 341 | 0.010 |
Why?
|
| Anemia, Hemolytic | 1 | 2003 | 162 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1989 | 1440 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1976 | 507 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1986 | 2265 | 0.010 |
Why?
|
| H-Y Antigen | 1 | 2001 | 42 | 0.010 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2001 | 40 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2001 | 74 | 0.010 |
Why?
|
| Polyribosomes | 1 | 2001 | 109 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2001 | 32 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2192 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1983 | 171 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 1986 | 1069 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2005 | 538 | 0.010 |
Why?
|
| Spectrophotometry | 2 | 1975 | 309 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2001 | 194 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 8002 | 0.010 |
Why?
|
| tau Proteins | 1 | 2012 | 2095 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1986 | 1134 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2001 | 189 | 0.010 |
Why?
|
| Turkey | 1 | 1981 | 254 | 0.010 |
Why?
|
| Papio | 1 | 1983 | 669 | 0.010 |
Why?
|
| Receptors, Mitogen | 1 | 2000 | 61 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2001 | 163 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2002 | 366 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1986 | 1173 | 0.010 |
Why?
|
| Smad Proteins | 1 | 2001 | 156 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2001 | 181 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8181 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1984 | 582 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 360 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 629 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2000 | 63 | 0.010 |
Why?
|
| Muscles | 1 | 1985 | 1576 | 0.010 |
Why?
|
| Nervous System | 1 | 2004 | 545 | 0.010 |
Why?
|
| Bronchi | 1 | 2004 | 845 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 926 | 0.010 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2000 | 77 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 2000 | 88 | 0.010 |
Why?
|
| Mosaicism | 1 | 1983 | 475 | 0.010 |
Why?
|
| Avian Proteins | 1 | 2000 | 80 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2001 | 740 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
| Nitroblue Tetrazolium | 2 | 1990 | 17 | 0.010 |
Why?
|
| Interleukins | 1 | 2004 | 782 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2004 | 1682 | 0.010 |
Why?
|
| Inhibins | 1 | 2000 | 210 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2000 | 191 | 0.010 |
Why?
|
| Larva | 1 | 2001 | 508 | 0.010 |
Why?
|
| Cyclins | 1 | 2001 | 594 | 0.010 |
Why?
|
| Probability | 1 | 1985 | 2477 | 0.010 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2002 | 455 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 389 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1986 | 1803 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10209 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2000 | 257 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 1999 | 129 | 0.010 |
Why?
|
| DNA Ligases | 1 | 1998 | 82 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1991 | 817 | 0.010 |
Why?
|
| Ear, Inner | 1 | 2003 | 425 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1995 | 899 | 0.010 |
Why?
|
| Activins | 1 | 2000 | 210 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2000 | 318 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 1999 | 144 | 0.010 |
Why?
|
| Organomercury Compounds | 1 | 1978 | 16 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 3839 | 0.010 |
Why?
|
| Fetoscopy | 1 | 1979 | 133 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 1611 | 0.010 |
Why?
|
| Hemin | 1 | 1978 | 51 | 0.010 |
Why?
|
| Avian myeloblastosis virus | 1 | 1977 | 20 | 0.010 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 1997 | 43 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 1998 | 251 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2001 | 1149 | 0.010 |
Why?
|
| Ouabain | 1 | 1978 | 247 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1999 | 410 | 0.010 |
Why?
|
| Family Health | 1 | 2002 | 1257 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1997 | 120 | 0.010 |
Why?
|
| Genes, Essential | 1 | 1998 | 185 | 0.010 |
Why?
|
| Asia | 1 | 1979 | 619 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1986 | 2199 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 1084 | 0.010 |
Why?
|
| Eye | 1 | 2001 | 712 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12725 | 0.010 |
Why?
|
| Methotrexate | 2 | 1976 | 1719 | 0.010 |
Why?
|
| Immunoassay | 2 | 1987 | 745 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2455 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 2042 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1997 | 136 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1996 | 138 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 1997 | 223 | 0.010 |
Why?
|
| Spherocytosis, Hereditary | 1 | 1996 | 83 | 0.010 |
Why?
|
| Cochlea | 1 | 2003 | 845 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2000 | 557 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2015 | 6937 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1977 | 211 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1979 | 497 | 0.010 |
Why?
|
| Spectrin | 1 | 1996 | 170 | 0.010 |
Why?
|
| Butyrates | 2 | 1993 | 169 | 0.010 |
Why?
|
| Collagen | 1 | 2004 | 2638 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 489 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2008 | 3312 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 2091 | 0.010 |
Why?
|
| Chemistry | 1 | 1976 | 347 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2002 | 1027 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2002 | 764 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1975 | 110 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1977 | 301 | 0.010 |
Why?
|
| Triticum | 1 | 1975 | 90 | 0.010 |
Why?
|
| Edema | 1 | 1980 | 766 | 0.010 |
Why?
|
| Longevity | 1 | 2003 | 1065 | 0.010 |
Why?
|
| Parainfluenza Virus 1, Human | 1 | 1975 | 25 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.010 |
Why?
|
| Friend murine leukemia virus | 1 | 1975 | 37 | 0.010 |
Why?
|
| Leukocytes | 1 | 1983 | 2026 | 0.010 |
Why?
|
| Public Policy | 1 | 1999 | 559 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1996 | 378 | 0.010 |
Why?
|
| G1 Phase | 1 | 1996 | 403 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2001 | 1359 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 625 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 1878 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1996 | 945 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22176 | 0.010 |
Why?
|
| Lung Diseases, Fungal | 1 | 1995 | 126 | 0.010 |
Why?
|
| Plants | 1 | 1975 | 327 | 0.010 |
Why?
|
| Blood | 1 | 1996 | 596 | 0.010 |
Why?
|
| Pentosyltransferases | 1 | 1973 | 62 | 0.010 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1993 | 98 | 0.010 |
Why?
|
| Butyric Acid | 1 | 1993 | 51 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 1995 | 157 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 12947 | 0.010 |
Why?
|
| Stem Cell Factor | 1 | 1993 | 195 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1973 | 286 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1995 | 242 | 0.010 |
Why?
|
| Peritonitis | 1 | 1995 | 368 | 0.010 |
Why?
|
| Glioma | 1 | 1987 | 3455 | 0.010 |
Why?
|
| Nitrosoguanidines | 1 | 1971 | 8 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3113 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1993 | 621 | 0.010 |
Why?
|
| Sarcoma | 1 | 2003 | 1801 | 0.010 |
Why?
|
| Thymine Nucleotides | 1 | 1971 | 57 | 0.010 |
Why?
|
| Proviruses | 1 | 1993 | 313 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1995 | 585 | 0.010 |
Why?
|
| Middle Aged | 5 | 2008 | 220895 | 0.010 |
Why?
|
| Sulfonic Acids | 1 | 1971 | 103 | 0.010 |
Why?
|
| Tritium | 1 | 1971 | 708 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1971 | 198 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1991 | 3688 | 0.010 |
Why?
|
| Insulin | 1 | 1986 | 6596 | 0.010 |
Why?
|
| Bradykinin | 1 | 1991 | 208 | 0.010 |
Why?
|
| Mutagens | 1 | 1971 | 179 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 5486 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 10090 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1991 | 659 | 0.010 |
Why?
|
| Ligases | 1 | 1971 | 333 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2001 | 3466 | 0.010 |
Why?
|
| rap GTP-Binding Proteins | 1 | 1989 | 24 | 0.010 |
Why?
|
| Duodenum | 1 | 1993 | 490 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2005 | 6630 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1976 | 1596 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1990 | 698 | 0.010 |
Why?
|
| Myometrium | 1 | 1990 | 174 | 0.010 |
Why?
|
| China | 2 | 1986 | 2369 | 0.010 |
Why?
|
| Folic Acid | 1 | 1976 | 1323 | 0.000 |
Why?
|
| Genetic Markers | 2 | 1986 | 2601 | 0.000 |
Why?
|
| Cytosol | 1 | 1991 | 888 | 0.000 |
Why?
|
| Blood Bactericidal Activity | 1 | 1988 | 124 | 0.000 |
Why?
|
| India | 2 | 1986 | 2348 | 0.000 |
Why?
|
| Optical Rotatory Dispersion | 1 | 1967 | 10 | 0.000 |
Why?
|
| 1-Deoxynojirimycin | 1 | 1987 | 18 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1990 | 561 | 0.000 |
Why?
|
| Capillaries | 1 | 1991 | 755 | 0.000 |
Why?
|
| Chemistry, Physical | 1 | 1967 | 154 | 0.000 |
Why?
|
| United States | 2 | 1999 | 72334 | 0.000 |
Why?
|
| Glucosamine | 1 | 1987 | 128 | 0.000 |
Why?
|
| Azo Compounds | 1 | 1967 | 117 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 800 | 0.000 |
Why?
|
| Zygote | 1 | 1987 | 115 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1993 | 2329 | 0.000 |
Why?
|
| Laos | 1 | 1986 | 27 | 0.000 |
Why?
|
| Immune Sera | 1 | 1987 | 606 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1988 | 681 | 0.000 |
Why?
|
| Paternity | 1 | 1986 | 14 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1995 | 1458 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1975 | 2846 | 0.000 |
Why?
|
| Deltaretrovirus | 1 | 1986 | 162 | 0.000 |
Why?
|
| Risk | 1 | 1978 | 9610 | 0.000 |
Why?
|
| Procarbazine | 1 | 1985 | 172 | 0.000 |
Why?
|
| Gelsolin | 1 | 1986 | 189 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1995 | 1408 | 0.000 |
Why?
|
| Vietnam | 1 | 1986 | 409 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1986 | 862 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 59243 | 0.000 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1985 | 100 | 0.000 |
Why?
|
| Leiomyoma | 1 | 1990 | 636 | 0.000 |
Why?
|
| Mercury | 1 | 1967 | 290 | 0.000 |
Why?
|
| Busulfan | 1 | 1985 | 258 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1985 | 487 | 0.000 |
Why?
|
| Iran | 1 | 1986 | 737 | 0.000 |
Why?
|
| RNA Caps | 1 | 1983 | 73 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1967 | 2496 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1986 | 853 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 58976 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1986 | 1510 | 0.000 |
Why?
|
| Demography | 1 | 1987 | 1648 | 0.000 |
Why?
|
| Cell Fractionation | 1 | 1982 | 251 | 0.000 |
Why?
|
| Rodentia | 1 | 1983 | 262 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1987 | 1866 | 0.000 |
Why?
|
| Uterine Neoplasms | 1 | 1990 | 1420 | 0.000 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 647 | 0.000 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1980 | 66 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1986 | 1078 | 0.000 |
Why?
|
| Chromatography | 1 | 1980 | 189 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1985 | 2218 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1985 | 974 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1994 | 11121 | 0.000 |
Why?
|
| Calcium | 1 | 1991 | 5722 | 0.000 |
Why?
|
| Europe | 1 | 1984 | 3422 | 0.000 |
Why?
|
| Papillomaviridae | 1 | 1983 | 1119 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 169289 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 3156 | 0.000 |
Why?
|
| Cytarabine | 1 | 1975 | 697 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1985 | 4445 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1985 | 3080 | 0.000 |
Why?
|